Get the app
US › Healthcare

CapsoVision, Inc. Common Stock (CV)

US · Healthcare · Medical Devices

$6.33+5.68%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$3.6M
Revenue YoY
+9.9%
Net profit
$-7.5M
EPS
$-0.15
EPS estimate
$-0.13
Net margin
-205.4%

EPS came in at -0.15 against a street estimate of -0.13 — a miss of 15.4%.

Key statistics

Market cap
$330.3M
Forward P/E
0.0
P/B
24.75
Book value
$0.26
EPS (TTM)
$-1.13
52-week high
$15.37
52-week low
$4.08
50-day MA
$6.42
200-day MA
$6.80

Analyst view

with an average price target of $9.50.

Shareholding

Insiders
32.04%
Institutions
10.35%

Largest institutional holders

FundStake
BlackRock Inc2.61%
Vanguard Capital Management, LLC2.05%
Geode Capital Management, LLC0.87%
State Street Corp0.51%
Vanguard Portfolio Management, LLC0.33%
Northern Trust Corp0.30%
Vanguard Fiduciary Trust Co0.18%
XTX Topco Ltd0.13%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for CapsoVision, Inc. Common Stock — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.